Clinical Trials Logo

Clinical Trial Summary

The corneal collagen cross linking is currently used in the treatment of keratoconus but this procedure has also a sterilizing non-specific effect on bacteria and fungus. So the corneal cross linking in association with the antibiotic treatment could result in a reduction of the duration of epithelial complete healing of the cornea.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02088970
Study type Interventional
Source Nantes University Hospital
Contact
Status Terminated
Phase N/A
Start date September 2014
Completion date April 2017

See also
  Status Clinical Trial Phase
Completed NCT02497365 - Besifloxacin in Bacterial Keratitis N/A
Recruiting NCT03918408 - Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions Phase 1
Completed NCT00651586 - Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers Phase 2
Recruiting NCT06451172 - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis Early Phase 1
Recruiting NCT02016989 - Matrix Therapy And Bacterial Keratitis N/A
Completed NCT00386958 - A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers Phase 2
Recruiting NCT04213885 - Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position Phase 2
Completed NCT01831206 - Collagen Cross-linking in Infectious Keratitis Trial Phase 2
Completed NCT03845374 - Prospective, Randomized Multi-Center Study of Using the Hyper-CLâ„¢ Lens in Subjects Suffering From Bacterial Keratitis N/A
Completed NCT00707005 - Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients N/A
Completed NCT05655689 - The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Not yet recruiting NCT06271772 - Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II Phase 3